Expert Opinion on Biological Therapy
Discipline | Therapeutics |
---|---|
Language | English |
Edited by | Michael Morse |
Publication details | |
History | 2001-present |
Publisher | Taylor & Francis |
Frequency | Monthly |
Impact factor | 3.974 (2017) |
Standard abbreviations ISO 4 (alt) · Bluebook (alt1 · alt2) NLM (alt) · MathSciNet (alt ) | |
ISO 4 | Expert Opin. Biol. Ther. |
Indexing CODEN (alt · alt2) · JSTOR (alt) · LCCN (alt) MIAR · NLM (alt) · Scopus | |
ISSN | 1471-2598 (print) 1744-7682 (web) |
LCCN | 2001243388 |
OCLC no. | 48476209 |
Links | |
|
Expert Opinion on Biological Therapy is a monthly peer-reviewed medical journal covering research on all aspects of biological therapy, including gene therapy and gene transfer technologies, therapeutic peptides and proteins, vaccines and antibodies, and cell- and tissue-based therapies. The journal is published by Taylor & Francis and the editor-in-chief is Michael Morse (Duke University Hospital). The journal was established in 2001 and according to the Journal Citation Reports, it has a 2017 impact factor of 3.974.[1] The journal is also indexed in MEDLINE.
References
- ^ "Expert Opinion on Biological Therapy". 2017 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2018.
External links
- Official website
- v
- t
- e
This article about a pharmacology journal is a stub. You can help Wikipedia by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page. |
- v
- t
- e